Titre:
  • Whole exome sequencing of pre-treatment biopsies from the neoALTTO trial to identify DNA aberrations associated with response to HER2-targeted therapies.
Auteur:Pusztai, Lajos; Shi, W; Jiang, T; Nuciforo, P; Holmes, E; Harbeck, Nadia; Sotiriou, Christos; Rimm, David D.L.; Hatzis, Christos; de la Peña, Lorena; Armour, A; Piccart-Gebhart, Martine; Baselga, J
Informations sur la publication:San Antonio Breast Cancer Symposium (December 11, 2015: San Antonio, Tx, USA)
Statut de publication:Non publié, 2015-12
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Langue:Anglais